A recent article by Paula Lorgelly and Amanda Adler looks at how the COVID-19 pandemic is impacting health technology assessment.
COVID-19 will have a lasting impact on life as we know it, they write, and it’s “likely that HTA will similarly adapt to this shock.”
“Our healthcare systems are changing rapidly, and our means of undertaking assessments of value will also need to change,” Lorgelly and Adler write. “HTA is not immune to COVID-19, but it can and will adapt.”
To read the full article on SpringerLink, click here.